A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Public ClinicalTrials.gov record NCT02960022. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) which has completed, at a minimum, the primary analysis or the study specified evaluation period.
Study identification
- NCT ID
- NCT02960022
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 900 participants
Conditions and interventions
Conditions
Interventions
- enzalutamide Drug
- abiraterone acetate Drug
- prednisone Drug
- Leuprolide acetate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 22, 2016 (Actual)
- Primary completion
- Jul 31, 2029 (Estimated)
- Completion
- Jul 31, 2029 (Estimated)
- Last update posted
- Oct 13, 2026
2016 – 2029
United States locations
- U.S. sites
- 46
- U.S. states
- 24
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site US10052 | Anchorage | Alaska | 99503 | — |
| Site US10011 | Tucson | Arizona | 85741 | — |
| Site US10040 | Los Angeles | California | 90024 | — |
| Site US10009 | Los Angeles | California | 90048 | — |
| Site US10008 | San Bernardino | California | 92404 | — |
| Site US10042 | San Diego | California | 92108 | — |
| Site US10028 | Stanford | California | 94305 | — |
| Site US10001 | Aurora | Colorado | 80045 | — |
| Site US10017 | Denver | Colorado | 80211 | — |
| Site US10050 | Washington D.C. | District of Columbia | 20037 | — |
| Site US10049 | Daytona Beach | Florida | 32114 | — |
| Site US10002 | Chicago | Illinois | 60637 | — |
| Springfield Clinic, LLP | Springfield | Illinois | 62701 | — |
| Site US10007 | Jeffersonville | Indiana | 47130 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Site US10066 | Lenexa | Kansas | 66214-1656 | — |
| Site US10029 | Towson | Maryland | 21204 | — |
| Site US10032 | St Louis | Missouri | 63110 | — |
| Nebraska Medical Hospital | Omaha | Nebraska | 68114 | — |
| Site US10023 | Omaha | Nebraska | 68130 | — |
| Site US10004 | Hackensack | New Jersey | 07601 | — |
| Site US10024 | Garden City | New York | 11530 | — |
| Site US10055 | New York | New York | 10065 | — |
| Site US10059 | New York | New York | 10065 | — |
| Hudson Valley Urology, PC | Poughkeepsie | New York | 12601 | — |
| Site US10053 | Syracuse | New York | 13210 | — |
| Site US10030 | Chapel Hill | North Carolina | 27599 | — |
| Site US10062 | Charlotte | North Carolina | 28207 | — |
| Site US10031 | Greensboro | North Carolina | 27403 | — |
| Eastern Urological Associates | Greenville | North Carolina | 27834 | — |
| Site US10046 | Winston-Salem | North Carolina | 27157 | — |
| Site US10035 | Cincinnati | Ohio | 45212 | — |
| Site US10022 | Springfield | Oregon | 97477 | — |
| Site US10027 | Lancaster | Pennsylvania | 17604 | — |
| Site US10005 | Pittsburgh | Pennsylvania | 15232 | — |
| Site US10018 | Charleston | South Carolina | 29414 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Site US10041 | Nashville | Tennessee | 37232-2765 | — |
| Site US10010 | Dallas | Texas | 75231 | — |
| Site US10034 | Houston | Texas | 77024 | — |
| Site US10043 | Houston | Texas | 77030 | — |
| Site US10014 | Norfolk | Virginia | 23502 | — |
| Site US10015 | Virginia Beach | Virginia | 23462 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
| Site US10038 | Seattle | Washington | 98109 | — |
| Site US10021 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 187 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02960022, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02960022 live on ClinicalTrials.gov.